Publication | Closed Access

Polymorphisms in Vascular Endothelial Growth Factor Receptor 2 Are Associated with Better Response Rates to Ranibizumab Treatment in Age-related Macular Degeneration

Ocular DiseaseOphthalmologyAge-related DiseasesImmunologyGenetic EpidemiologyPathologyAge-related Macular DegenerationAre AssociatedVascular BiologyEye HealthPublic HealthMedicineBetter Response